Literature DB >> 10611720

Cytomegalovirus: virological facts for clinicians.

B Bodaghi1, S Michelson.   

Abstract

Human cytomegalovirus (HCMV) is a complex DNA virus encoding more than 200 viral proteins. This highly adapted opportunist agent has developed several ways to evade the immune system. Among all clinical features due to HCMV, retinitis occurs especially in severely immunosuppressed patients, particularly during the end phase of HIV infection. Highly active antiretroviral therapy (HAART) has significantly reduced the incidence of this complication. However, in this HAART era, we observe the emergence of new clinical patterns in patients presenting with cicatricial HCMV retinitis. These patterns could be potentially related to immune mechanisms directed against viral antigens expressed at the surface of retinal cells that are still latently infected without any viral replication. We used a model of human retinal pigment epithelial (RPE) cells to evaluate virus-host interactions in the presence of different cytokines in the eye which play a major role in immunological or infectious conditions. Two different enzymatic pathways seem to be particularly involved during infection. Lack of tryptophan and production of nitric oxide seem to block HCMV replication in RPE cells. We propose a model to explain some of the mechanisms involved during severe immunosuppression and also after immune recovery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10611720     DOI: 10.1076/ocii.7.3.133.3998

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Vitreal pharmacokinetics of peptide-transporter-targeted prodrugs of ganciclovir in conscious animals.

Authors:  Kumar G Janoria; Sai H S Boddu; Subramanian Natesan; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2010-06       Impact factor: 2.671

2.  Vitreal pharmacokinetics of biotinylated ganciclovir: role of sodium-dependent multivitamin transporter expressed on retina.

Authors:  Kumar G Janoria; Sai H S Boddu; Zhiying Wang; Durga K Paturi; Swapan Samanta; Dhananjay Pal; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2009-02       Impact factor: 2.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.